|

Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA)

RECRUITINGN/ASponsored by Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Actively Recruiting
PhaseN/A
SponsorRobert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Started2026-03-31
Est. completion2027-06-30
Eligibility
Age18 Years – 99 Years
SexFEMALE
Healthy vol.Accepted

Summary

This randomized, controlled, single-center trial investigates the effects of auricular acupressure, administered according to the National Acupuncture Detoxification Association (NADA) protocol, on perioperative anxiety and pain in patients with a first diagnosis of breast cancer undergoing therapeutic breast surgery. Participants receiving auricular acupressure according to the NADA protocol will be compared with patients receiving standard care alone.

Eligibility

Age: 18 Years – 99 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female gender
* Breast cancer patients undergoing therapeutic breast surgery at Robert Bosch Hospital following an initial diagnosis.
* Signed informed consent form.

Exclusion Criteria:

* An anxiety disorder that has been diagnosed within the last 12 months.
* A mental state that, in the opinion of the investigator, prevents the patient from participating in the study.
* Use of hearing aids.
* Skin irritations or eczema in the ear.
* Pregnancy
* Insufficient knowledge of German
* Unwillingness to store and share personal medical data within the framework of the protocol
* Missing or incomplete declaration of consent
* Receipt of acupuncture treatment (including NADA ear acupuncture or acupressure) in the last three months.

Conditions4

AnxietyBreast CancerBreast Cancer FemalesCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.